Novo Nordisk's drug officially hit the shelves on Monday, marking its availability despite being greenlit in Canada since ...
1:38 Wegovy weight loss benefits sustained in longest medical trial to date Wegovy has become the first approved treatment in Canada to address both obesity and the risk of heart-related ...
Health Canada has approved Novo Nordisk's weight-loss drug Wegovy to reduce the risk of non-fatal heart attack, the drug maker says. Novo Nordisk said Wednesday that Wegovy is the first Health ...
Health Canada has approved Novo Nordisk’s semaglutide injection, Wegovy, marking it as the first treatment in the country authorised to assist in chronic weight management and to reduce the risk ...